Caveolae, lipid rafts, and vascular disease

Trends in Cardiovascular Medicine

Volumn 15, Issue 3, 2005, Pages 92-96

  Li, Xiang An ^a   Everson, William V ^a   Smart, Eric J ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMICAL MARKER; CAVEOLIN; CHOLESTEROL; ENDOTHELIAL NITRIC OXIDE SYNTHASE;

CARDIOVASCULAR SYSTEM; CAVEOLA; CELL MEMBRANE; CHOLESTEROL BLOOD LEVEL; HEART VENTRICLE HYPERTROPHY; HOMEOSTASIS; HUMAN; KNOCKOUT MOUSE; LIPID COMPOSITION; LIPID RAFT; MEMBRANE STRUCTURE; MORPHOLOGY; NONHUMAN; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SHORT SURVEY; SIGNAL PROCESSING; VASCULAR DISEASE;

EID: 22544443358     PISSN: 10501738     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tcm.2005.04.001     Document Type: Review

References (49)

1. RG Anderson The caveolae membrane system Annu Rev Biochem 67 1998 199 225
2. RG Anderson, and K Jacobson A role for lipid shells in targeting proteins to caveolae, rafts, and other lipid domains Science 296 2002 1821 1825
3. D Brown, and GL Waneck Glycosyl-phosphatidylinositol-anchored membrane proteins J Am Soc Nephrol 3 1992 895 906
4. M Bucci, JP Gratton, and RD Rudic In vivo delivery of the caveolin-1 scaffolding domain inhibits nitric oxide synthesis and reduces inflammation Nat Med 6 2000 1362 1367
5. G Cao, G Yang, and TL Timme Disruption of the caveolin-1 gene impairs renal calcium reabsorption and leads to hypercalciuria and urolithiasis Am J Pathol 162 2003 1241 1248
6. WJ Chang, KG Rothberg, BA Kamen, and RG Anderson Lowering the cholesterol content of MA104 cells inhibits receptor-mediated transport of folate J Cell Biol 118 1992 63 69
7. M Drab, P Verkade, and M Elger Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice Science 293 2001 2449 2452
8. PE Fielding, and CJ Fielding Plasma membrane caveolae mediate the efflux of cellular free cholesterol Biochemistry 34 1995 14288 14292
9. PG Frank, H Lee, and DS Park Genetic ablation of caveolin-1 confers protection against atherosclerosis Arterioscler Thromb Vasc Biol 24 2004 98 105
10. Y Fu, A Hoang, and G Escher Expression of caveolin-1 enhances cholesterol efflux in hepatic cells J Biol Chem 279 2004 14140 14146
11. F Galbiati, JA Engelman, and D Volonté Caveolin-3 null mice show a loss of caveolae, changes in the microdomain distribution of the dystrophin-glycoprotein complex, and t-tubule abnormalities J Biol Chem 276 2001 21425 21433
12. G Garcia-Cardena, P Martasek, and BS Masters Dissecting the interaction between nitric oxide synthase (NOS) and caveolin. Functional significance of the NOS caveolin binding domain in vivo J Biol Chem 272 1997 25437 25440
13. G Garcia-Cardena, P Oh, and J Liu Targeting of nitric oxide synthase to endothelial cell caveolae via palmitoylation: implications for nitric oxide signaling Proc Natl Acad Sci USA 93 1996 6448 6453
14. S Ghosh, R Gachhui, and C Crooks Interaction between caveolin-1 and the reductase domain of endothelial nitric-oxide synthase. Consequences for catalysis J Biol Chem 273 1998 22267 22271
15. JR Glenney The sequence of human caveolin reveals identity with VIP21, a component of transport vesicles FEBS Lett 314 1992 45 48
16. JR Glenney, and D Soppet Sequence and expression of caveolin, a protein component of caveolae plasma membrane domains phosphorylated on tyrosine in Rous sarcoma virus-transformed fibroblasts Proc Natl Acad Sci USA 89 1992 10517 10521
17. JL Goldstein, MS Brown, and RG Anderson Receptor-mediated endocytosis: concepts emerging from the LDL receptor system Annu Rev Cell Biol 1 1985 1 39
18. MC Gong, ME Wilson, and T Kelly HDL-associated estradiol stimulates endothelial NO synthase and vasodilation in an SR-BI-dependent manner J Clin Invest 111 2003 1579 1587
19. JP Gratton, P Bernatchez, and WC Sessa Caveolae and caveolins in the cardiovascular system Circ Res 94 2004 1408 1417
20. Y Hagiwara, T Sasaoka, and K Araishi Caveolin-3 deficiency causes muscle degeneration in mice Hum Mol Genet 9 2000 3047 3054
21. H Ju, R Zou, and VJ Venema Direct interaction of endothelial nitric-oxide synthase and caveolin-1 inhibits synthase activity J Biol Chem 272 1997 18522 18525
22. JW Knowles, RL Reddick, and JC Jennette Enhanced atherosclerosis and kidney dysfunction in eNOS (-/-)Apoe(-/-) mice are ameliorated by enalapril treatment J Clin Invest 105 2000 451 458
23. M Krieger Charting the fate of the "good cholesterol": identification and characterization of the high-density lipoprotein receptor SR-BI Annu Rev Biochem 68 1999 523 558
24. PJ Kuhlencordt, R Gyurko, and F Han Accelerated atherosclerosis, aortic aneurysm formation, and ischemic heart disease in apolipoprotein E/endothelial nitric oxide synthase double-knockout mice Circulation 104 2001 448 454
25. TV Kurzchalia, P Dupree, and RG Parton VIP21, a 21-kD membrane protein is an integral component of trans-Golgi-network-derived transport vesicles J Cell Biol 118 1992 1003 1014
26. X-A Li, WB Titlow, and BA Jackson High-density lipoprotein binding to scavenger receptor class B, type I activates endothelial nitric oxide synthase in a ceramide-dependent manner J Biol Chem 277 2002 11058 11063
27. J Liu, G Garcia-Cardena, and WC Sessa Palmitoylation of endothelial nitric oxide synthase is necessary for optimal stimulate release of nitric oxide: implications for caveolae localization Biochemistry 35 1996 13277 13281
28. 2+-calmodulin and caveolin J Biol Chem 272 1997 15583 15586
29. JB Michel, O Feron, and K Sase Caveolin versus calmodulin. Counterbalancing allosteric modulators of endothelial nitric oxide synthase J Biol Chem 272 1997 25907 25912
30. C Mineo, IS Yuhanna, and MJ Quon High density lipoprotein-induced endothelial nitric-oxide synthase activation is mediated by Akt and MAP kinases J Biol Chem 278 2003 9142 9149
31. M Murata, J Peranen, and R Schreiner VIP21/caveolin is a cholesterol-binding protein Proc Natl Acad Sci USA 92 1995 10339 10343
32. DS Park, SE Woodman, and W Schubert Caveolin 1/3 double-knockout mice are viable, but lack both muscle and non-muscle caveolae, and develop a severe cardiomyopathic phenotype Am J Path 160 2002 2207 2217
33. LJ Pike, X Han, and KN Chung Lipid rafts are enriched in enriched in arachidonic acid and plasmenylethanolamine and their composition is independent of caveolin-1 expression: a quantitative electrospray ionization/mass spectrometric analysis Biochemistry 41 2002 2075 2088
34. B Razani, JA Engelman, and XB Wang Caveolin-1 null mice are viable but show evidence of hyperproliferative and vascular abnormalities J Biol Chem 276 2001 38121 38138
35. B Razani, XB Wang, and JA Engelman Caveolin-2 deficient mice show evidence of severe pulmonary dysfunction without disruption of caveolae Mol Biol Cell 22 2002 2329 2344
36. KG Rothberg, JE Heuser, and WC Donzell Caveolin, a protein component of caveolae membrane coats Cell 68 1992 673 682
37. KG Rothberg, Y Ying, and BA Kamen Cholesterol controls the clustering of the glycophospholipid-anchored membrane receptor for 5-methyltetrahydrofolate J Cell Biol 111 1990 2931 2938
38. WC Sessa Atheroprotection in the absence of "caves": is it the fat, the vessels, or both? Arterios Thromb Vasc Biol 24 2004 4 6
39. PW Shaul Regulation of endothelial nitric oxide synthase: location, location, location Annu Rev Physiol 64 2002 749 774
40. PW Shaul Endothelial nitric oxide synthase, caveolae and the development of atherosclerosis J Physiol 547 2003 21 33
41. K Simons, and E Ikonen Functional rafts in cell membranes Nature 387 1997 569 572
42. EJ Smart, GA Graf, and MA McNiven Caveolins, liquid-ordered domains, and signal transduction Mol Cell Biol 19 1999 7289 7304
43. B Trigatti, A Rigotti, and M Krieger The role of the high-density lipoprotein receptor SR-BI in cholesterol metabolism Curr Opin Lipidol 11 2000 123 131
44. A Uittenbogaard, WV Everson, and SV Matveev Cholesteryl ester is transported from caveolae to internal membranes as part of a caveolin-annexin II lipid-protein complex J Biol Chem 277 2002 4925 4931
45. A Uittenbogaard, PW Shaul, and IS Yuhanna High density lipoprotein prevents oxidized low density lipoprotein-induced inhibition of endothelial nitric-oxide synthase localization and activation in caveolae J Biol Chem 275 2000 11278 11283
46. A Uittenbogaard, and EJ Smart Palmitoylation of caveolin-1 is required for cholesterol binding, chaperone complex formation, and rapid transport of cholesterol to caveolae J Biol Chem 275 2000 25595 25599
47. E Yamada The fine structure of the gall bladder epithelium of the mouse J Biophys Biochem Cytol 1 1955 445 458
48. IS Yuhanna, Y Zhu, and BE Cox High-density lipoprotein binding to scavenger receptor-BI activates endothelial nitric oxide synthase Nat Med 7 2001 853 857
49. YY Zhao, Y Liu, and RV Stan Defects in caveolin-1 cause dilated cardiomyopathy and pulmonary hypertension in knockout mice Proc Natl Acad Sci USA 99 2002 11375 11380